Metro Healthcare Berhad Future Growth

KLSE:METRO - Analysts future estimates and past financials data (MYR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	64	N/A	N/A	N/A	1
12/31/2025	58	N/A	N/A	N/A	1
12/31/2024	51	N/A	N/A	N/A	1
6/30/2024	47	7	7	12	N/A
3/31/2024	46	6	7	11	N/A
12/31/2023	45	6	7	11	N/A
9/30/2023	44	6	7	10	N/A
6/30/2023	42	6	6	9	N/A
3/31/2023	41	5	6	9	N/A
12/31/2022	40	5	5	9	N/A
9/30/2022	41	6	4	8	N/A
6/30/2022	41	8	3	8	N/A
3/31/2022	42	9	5	10	N/A
12/31/2021	42	9	7	12	N/A
9/30/2021	40	9	7	13	N/A
6/30/2021	38	8	7	13	N/A
3/31/2021	33	7	5	10	N/A
12/31/2020	28	5	3	7	N/A
9/30/2020	26	4	3	6	N/A
6/30/2020	23	3	3	5	N/A
3/31/2020	23	3	3	5	N/A
12/31/2019	23	2	3	4	N/A
9/30/2019	22	2	2	4	N/A
6/30/2019	21	2	1	4	N/A
3/31/2019	21	2	1	3	N/A
12/31/2018	20	2	0	2	N/A
9/30/2018	1	0	-7	-8	N/A
6/30/2018	10	2	0	0	N/A
3/31/2018	5	2	N/A	0	N/A
12/31/2017	0	2	N/A	0	N/A
12/31/2016	17	3	N/A	3	N/A
12/31/2015	16	3	N/A	4	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if METRO's forecast earnings growth is above the savings rate (3.6%).

Earnings vs Market: Insufficient data to determine if METRO's earnings are forecast to grow faster than the MY market

High Growth Earnings: Insufficient data to determine if METRO's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: METRO's revenue (11.9% per year) is forecast to grow faster than the MY market (6.1% per year).

High Growth Revenue: METRO's revenue (11.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if METRO's Return on Equity is forecast to be high in 3 years time

Metro Healthcare Berhad Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Recent updates

Now 24% undervalued

Metro Healthcare Berhad has completed a Follow-on Equity Offering in the amount of MYR 39.15625 million.

Metro Healthcare Berhad has filed a Follow-on Equity Offering.

Metro Healthcare Berhad, Annual General Meeting, Apr 01, 2024

Metro Healthcare Berhad Appoints CIK ROSE ZILAWATI BINTI MOHAMED ARIFIN as Independent and Non Executive Director

Metro Healthcare Berhad, Annual General Meeting, Jun 22, 2023

Metro Healthcare Berhad Appoints Lee Siew Fun as Joint Secretary

Insufficient new directors

Full year 2022 earnings released: EPS: RM0.008 (vs RM0.015 in FY 2021)

Insufficient new directors

Insufficient new directors

Insufficient new directors

Insufficient new directors

Metro Healthcare Berhad Announces Registration of Tee Siew Kai as Non Executive Director

Metro Healthcare Berhad Appoints Tea Sor Hua as Company Secretary

Metro Healthcare Berhad Proposes Interim Single-Tier Dividend for the Financial Year Ending 31 December 2022

Estimating The Fair Value Of Metro Healthcare Berhad (KLSE:MHCARE)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Robust Earnings May Not Tell The Whole Story For Metro Healthcare Berhad (KLSE:MHCARE)

First half 2021 earnings released: EPS RM0.021 (vs RM0.009 in 1H 2020)

Independent Non-Executive Director Chiang Koay has left the company

Investor sentiment improved over the past week

Do Metro Healthcare Berhad's (KLSE:MHCARE) Earnings Warrant Your Attention?

Calculating The Fair Value Of Metro Healthcare Berhad (KLSE:MHCARE)

Investors Who Bought Metro Healthcare Berhad (KLSE:MHCARE) Shares Three Years Ago Are Now Up 261%

Metro Healthcare Berhad has completed a Follow-on Equity Offering in the amount of MYR 4.593 million.

With EPS Growth And More, Metro Healthcare Berhad (KLSE:MHCARE) Is Interesting

Full year 2020 earnings released: EPS RM0.027 (vs RM0.011 in FY 2019)

Estimating The Intrinsic Value Of Metro Healthcare Berhad (KLSE:MHCARE)

First half earnings released

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies